Collaboration - August 26, 2014
Recipharm collaborates with Isofol Medical
Recipharm forms a new collaboration with Isofol Medical to manufacture Isofol’s drug candidate Modufolin. Furthermore, the life science sector investor Recipharm Venture Fund has announced that it has invested SEK 8 million in Isofol Medical. Isofol Medical AB is currently evaluating its drug candidate Modufolin in two clinical phase I/II studies. Modufolin is an endogenous […]
Acquisition - August 19, 2014
Recipharm acquires Corvette Pharmaceutical Services Group
The Swedish contract development and manufacturing organisation Recipharm has signed an agreement to acquire Milan based Corvette Pharmaceutical Services Group for SEK 1.1 billion. The sellers of Corvette Group are LBO Italia Investimenti Srl (“LBO Italia”), as controlling shareholder, and some private investors, holding minority interests. Corvette Pharmaceutical Services Group (consisting of Corvette Group SpA and […]
Business Award - April 11, 2014
Founders of Recipharm awarded enterprise medal
Lars Backsell and Thomas Eldered has received enterprise medal for excellent entrepreneurship. The two founders received the medal for the development of Recipharm to become one of the world’s largest contract manufacturing and development organisations of pharmaceuticals. “We are very proud of this award which reflects not only our actions but also the work of […]
